Manufacturers register to participate in the Pneumococcal AMC

in page functions

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate

Geneva, 23 September 2009 - The Serum Institute is one of the companies that has begun the registration process in order to participate. Several companies have inquired about the pilot.

Information about the number and names of manufacturers is confidential unless a firm requests its information to be made public.

For more information about the AMC registration process please contact: amc@gavialliance.org

440 million

Since 2000, 440 million additional children have been immunised through GAVI support to routine immunisation in the world's poorest countries.

WHO-UNICEF 2013

More facts...

close icon

modal window here